Product Wiki · Recalls · U.S. CPSC

Recall 16723 — Children's bikes

U.S. CPSC · United States · 2016-01-21

AI-assisted, human-edited — this page is drafted with AI from public-source data, then reviewed before publication. How we use AI →
Agency
U.S. CPSC
Recall identifier
16723
Date of alert
2016-01-21
Country / jurisdiction
United States
Risk type
recall
Product category
consumer_product
Reported risk: This recall includes all Chillafish BMXie, Chillafish Jack and Chillafish Josie balance bikes. The bikes were designed for children ages 2 to 5 and have no pedals and no chains. BMXie bikes are made of plastic. The bikes are about 31.5 inches long with a seat that can be adjusted from about 12.5 inches high to about 15.5 inches high and have a detachable foot support. BMXie bikes were sold in the colors blue, lime green, pink, red and yellow. Item reference number CPMX01BLU, CPMX01LIM, CPMX01PIN, CPMX01RED or CPMX01YEL is on a label on the bottom of the bike frame. Jack and Josie bikes have steel frames. The bikes are about 34 inches long with a seat that can be adjusted from about 14 inches high to about 17 inches high. Jack bikes were sold in a black and orange color scheme with flames on the crosstube and item reference number CPJJ02BLA on a label on the bottom of the bike frame. Josie bikes were sold in a white and pink color scheme with flowers on the crosstube and item reference number CPJJ02WHI on a label on the bottom of the bike frame. Hazards: Overinflated tires can cause the wheel rims to crack and send pieces of the plastic rim flying, posing a laceration hazard to consumers.
Primary source: https://www.cpsc.gov/Recalls/2016/Chillafish-Recalls-Childrens-Balance-Bikes

Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.

ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.